E-232 Mid-term results of aneurysm treatment with the new surpass evolve flow diverter: a multicenter experience
Sign Up to like & getrecommendations! Published in 2020 at "Journal of NeuroInterventional Surgery"
DOI: 10.1136/neurintsurg-2020-snis.263
Abstract: Purpose Flow diverters have become a safe and well-accepted treatment option for intracranial aneurysms of most sizes in the anterior and posterior circulation. Surpass Evolve (SE, Stryker Neurovascular, Kalamazoo, Michigan, USA) is a new flow… read more here.
Keywords: stryker; treatment; surpass evolve; mid term ... See more keywords